Skip to main content
Top
Published in: Current Hypertension Reports 12/2022

09-11-2022 | Hypertension | Hypertension and the Heart (B Upadhya, Section Editor)

Hypertension Across a Woman’s Life Cycle

Authors: Lama Ghazi, Rahul V. Annabathula, Natalie A. Bello, Li Zhou, Richard Brandon Stacey, Bharathi Upadhya

Published in: Current Hypertension Reports | Issue 12/2022

Login to get access

Abstract

Purpose of Review

We reviewed the effects of hypertension and the means to prevent and treat it across the spectrum of a woman’s lifespan and identified gaps in sex-specific mechanisms contributing to hypertension in women that need to be addressed.

Recent Findings

Hypertension continues to be an important public health problem for women across all life stages from adolescence through pregnancy, menopause, and older age. There remain racial, ethnic, and socioeconomic differences in hypertension rates not only overall but also between the sexes. Blood pressure cutoffs during pregnancy have not been updated to reflect the 2017 ACC/AHA changes due to a lack of data. Additionally, the mechanisms behind hypertension development in menopause, including sex hormones and genetic factors, are not well understood.

Summary

In the setting of increasing inactivity and obesity, along with an aging population, hypertension rates are increasing in women. Screening and management of hypertension throughout a women’s lifespan are necessary to reduce the burden of cardiovascular disease, and further research to understand sex-specific hypertension mechanisms is needed.
Literature
2.
go back to reference Collaborators GRF. Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990–2017: A systematic analysis for the global burden of disease study 2017. Lancet. 2018;392:1923–94.CrossRef Collaborators GRF. Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990–2017: A systematic analysis for the global burden of disease study 2017. Lancet. 2018;392:1923–94.CrossRef
3.
go back to reference Centers for Disease Control and Prevention. Hypertension cascade: hypertension prevalence, treatment and control estimates among U.S. adults aged 18 years and older applying the criteria from the American College of Cardiology and American Heart Association’s 2017 Hypertension Guideline—NHANES 2015–2018. Atlanta, GA: U.S. Department of Health and Human Services; 2021. https://www.cdc.gov/bloodpressure/facts.htm. Accessed 15 Sept 2022. Centers for Disease Control and Prevention. Hypertension cascade: hypertension prevalence, treatment and control estimates among U.S. adults aged 18 years and older applying the criteria from the American College of Cardiology and American Heart Association’s 2017 Hypertension Guideline—NHANES 2015–2018. Atlanta, GA: U.S. Department of Health and Human Services; 2021. https://​www.​cdc.​gov/​bloodpressure/​facts.​htm. Accessed 15 Sept 2022.
4.
5.
go back to reference Zhao B, Jose PO, Pu J, Chung S, Ancheta IB, Fortmann SP, et al. Racial/ethnic differences in hypertension prevalence, treatment, and control for outpatients in northern california 2010–2012. Am J Hypertens. 2015;28:631–9.PubMedCrossRef Zhao B, Jose PO, Pu J, Chung S, Ancheta IB, Fortmann SP, et al. Racial/ethnic differences in hypertension prevalence, treatment, and control for outpatients in northern california 2010–2012. Am J Hypertens. 2015;28:631–9.PubMedCrossRef
6.
go back to reference de Munter JS, Agyemang C, van Valkengoed IG, Bhopal R, Stronks K. Sex difference in blood pressure among South Asian diaspora in Europe and North America and the role of BMI: a meta-analysis. J Hum Hypertens. 2011;25:407–17.PubMedCrossRef de Munter JS, Agyemang C, van Valkengoed IG, Bhopal R, Stronks K. Sex difference in blood pressure among South Asian diaspora in Europe and North America and the role of BMI: a meta-analysis. J Hum Hypertens. 2011;25:407–17.PubMedCrossRef
7.
go back to reference Mills KT, Bundy JD, Kelly TN, Reed JE, Kearney PM, Reynolds K, et al. Global disparities of hypertension prevalence and control: a systematic analysis of population-based studies from 90 countries. Circulation. 2016;134:441–50.PubMedPubMedCentralCrossRef Mills KT, Bundy JD, Kelly TN, Reed JE, Kearney PM, Reynolds K, et al. Global disparities of hypertension prevalence and control: a systematic analysis of population-based studies from 90 countries. Circulation. 2016;134:441–50.PubMedPubMedCentralCrossRef
8.
go back to reference Lu J, Lu Y, Wang X, Li X, Linderman GC, Wu C, et al. Prevalence, awareness, treatment, and control of hypertension in china: data from 1·7 million adults in a population-based screening study (china peace million persons project). Lancet. 2017;390:2549–58.PubMedCrossRef Lu J, Lu Y, Wang X, Li X, Linderman GC, Wu C, et al. Prevalence, awareness, treatment, and control of hypertension in china: data from 1·7 million adults in a population-based screening study (china peace million persons project). Lancet. 2017;390:2549–58.PubMedCrossRef
9.
go back to reference Mozaffarian D, Benjamin EJ, Go AS, Arnett DK, Blaha MJ, Cushman M, et al. Subcommittee AHASCaSS: Heart disease and stroke statistics–2015 update: a report from the american heart association. Circulation. 2015;131:e29-322.PubMed Mozaffarian D, Benjamin EJ, Go AS, Arnett DK, Blaha MJ, Cushman M, et al. Subcommittee AHASCaSS: Heart disease and stroke statistics–2015 update: a report from the american heart association. Circulation. 2015;131:e29-322.PubMed
10.
go back to reference Gerdts E, Okin PM, de Simone G, Cramariuc D, Wachtell K, Boman K, et al. Gender differences in left ventricular structure and function during antihypertensive treatment: the losartan intervention for endpoint reduction in hypertension study. Hypertension. 2008;51:1109–14.PubMedCrossRef Gerdts E, Okin PM, de Simone G, Cramariuc D, Wachtell K, Boman K, et al. Gender differences in left ventricular structure and function during antihypertensive treatment: the losartan intervention for endpoint reduction in hypertension study. Hypertension. 2008;51:1109–14.PubMedCrossRef
11.
go back to reference Gerdts E, Izzo R, Mancusi C, Losi MA, Manzi MV, Canciello G, et al. Left ventricular hypertrophy offsets the sex difference in cardiovascular risk (the campania salute network). Int J Cardiol. 2018;258:257–61.PubMedCrossRef Gerdts E, Izzo R, Mancusi C, Losi MA, Manzi MV, Canciello G, et al. Left ventricular hypertrophy offsets the sex difference in cardiovascular risk (the campania salute network). Int J Cardiol. 2018;258:257–61.PubMedCrossRef
12.
go back to reference Patel SA, Winkel M, Ali MK, Narayan KM, Mehta NK. Cardiovascular mortality associated with 5 leading risk factors: national and state preventable fractions estimated from survey data. Ann Intern Med. 2015;163:245–53.PubMedCrossRef Patel SA, Winkel M, Ali MK, Narayan KM, Mehta NK. Cardiovascular mortality associated with 5 leading risk factors: national and state preventable fractions estimated from survey data. Ann Intern Med. 2015;163:245–53.PubMedCrossRef
13.
go back to reference Falkstedt D, Koupil I, Hemmingsson T. Blood pressure in late adolescence and early incidence of coronary heart disease and stroke in the Swedish 1969 conscription cohort. J Hypertens. 2008;26:1313–20.PubMedCrossRef Falkstedt D, Koupil I, Hemmingsson T. Blood pressure in late adolescence and early incidence of coronary heart disease and stroke in the Swedish 1969 conscription cohort. J Hypertens. 2008;26:1313–20.PubMedCrossRef
14.
go back to reference Högström G, Nordström A, Eriksson M, Nordström P. Risk factors assessed in adolescence and the later risk of stroke in men: a 33-year follow-up study. Cerebrovasc Dis. 2015;39:63–71.PubMedCrossRef Högström G, Nordström A, Eriksson M, Nordström P. Risk factors assessed in adolescence and the later risk of stroke in men: a 33-year follow-up study. Cerebrovasc Dis. 2015;39:63–71.PubMedCrossRef
15.
go back to reference Dost A, Bechtold S, Fink K, Bonfig W, Wiemann D, Kapellen TM, et al. Center iD-SatGDR: 2017 American Academy Of Pediatrics Clinical Practice guideline: impact on prevalence of arterial hypertension in children and adolescents with type 1 diabetes. Diabetes Care. 2020;43:1311–8.PubMedCrossRef Dost A, Bechtold S, Fink K, Bonfig W, Wiemann D, Kapellen TM, et al. Center iD-SatGDR: 2017 American Academy Of Pediatrics Clinical Practice guideline: impact on prevalence of arterial hypertension in children and adolescents with type 1 diabetes. Diabetes Care. 2020;43:1311–8.PubMedCrossRef
16.
go back to reference Al Kibria GM, Swasey K, Sharmeen A, Day B. Estimated change in prevalence and trends of childhood blood pressure levels in the United States after application of the 2017 AAP guideline. Prev Chronic Dis. 2019;16:E12.PubMedPubMedCentralCrossRef Al Kibria GM, Swasey K, Sharmeen A, Day B. Estimated change in prevalence and trends of childhood blood pressure levels in the United States after application of the 2017 AAP guideline. Prev Chronic Dis. 2019;16:E12.PubMedPubMedCentralCrossRef
17.
go back to reference Sorof J, Daniels S. Obesity hypertension in children: a problem of epidemic proportions. Hypertension. 2002;40:441–7.PubMedCrossRef Sorof J, Daniels S. Obesity hypertension in children: a problem of epidemic proportions. Hypertension. 2002;40:441–7.PubMedCrossRef
18.
go back to reference Falkner B, Gidding SS, Ramirez-Garnica G, Wiltrout SA, West D, Rappaport EB. The relationship of body mass index and blood pressure in primary care pediatric patients. J Pediatr. 2006;148:195–200.PubMedCrossRef Falkner B, Gidding SS, Ramirez-Garnica G, Wiltrout SA, West D, Rappaport EB. The relationship of body mass index and blood pressure in primary care pediatric patients. J Pediatr. 2006;148:195–200.PubMedCrossRef
19.
go back to reference Archbold KH, Vasquez MM, Goodwin JL, Quan SF. Effects of sleep patterns and obesity on increases in blood pressure in a 5-year period: report from the Tucson children’s assessment of sleep apnea study. J Pediatr. 2012;161:26–30.PubMedPubMedCentralCrossRef Archbold KH, Vasquez MM, Goodwin JL, Quan SF. Effects of sleep patterns and obesity on increases in blood pressure in a 5-year period: report from the Tucson children’s assessment of sleep apnea study. J Pediatr. 2012;161:26–30.PubMedPubMedCentralCrossRef
20.
go back to reference Grandi AM, Gaudio G, Fachinetti A, Bianchi L, Nardo B, Zanzi P, et al. Hyperinsulinemia, family history of hypertension, and essential hypertension. Am J Hypertens. 1996;9:732–8.PubMedCrossRef Grandi AM, Gaudio G, Fachinetti A, Bianchi L, Nardo B, Zanzi P, et al. Hyperinsulinemia, family history of hypertension, and essential hypertension. Am J Hypertens. 1996;9:732–8.PubMedCrossRef
21.
go back to reference von Eiff AW, Gogolin E, Jacobs U, Neus H. Ambulatory blood pressure in children followed for 3 years. Influence of sex and family history of hypertension. Clin Exp Hypertens A. 1986;8:577–81. von Eiff AW, Gogolin E, Jacobs U, Neus H. Ambulatory blood pressure in children followed for 3 years. Influence of sex and family history of hypertension. Clin Exp Hypertens A. 1986;8:577–81.
22.
go back to reference Munger RG, Prineas RJ, Gomez-Marin O. Persistent elevation of blood pressure among children with a family history of hypertension: the Minneapolis children’s blood pressure study. J Hypertens. 1988;6:647–53.PubMedCrossRef Munger RG, Prineas RJ, Gomez-Marin O. Persistent elevation of blood pressure among children with a family history of hypertension: the Minneapolis children’s blood pressure study. J Hypertens. 1988;6:647–53.PubMedCrossRef
23.
go back to reference Cheung EL, Bell CS, Samuel JP, Poffenbarger T, Redwine KM, Samuels JA. Race and obesity in adolescent hypertension. Pediatrics. 2017;139. Cheung EL, Bell CS, Samuel JP, Poffenbarger T, Redwine KM, Samuels JA. Race and obesity in adolescent hypertension. Pediatrics. 2017;139.
24.
go back to reference Ogunniyi MO, Commodore-Mensah Y, Ferdinand KC. Race, ethnicity, hypertension, and heart disease: Jacc focus seminar 1/9. J Am Coll Cardiol. 2021;78:2460–70.PubMedCrossRef Ogunniyi MO, Commodore-Mensah Y, Ferdinand KC. Race, ethnicity, hypertension, and heart disease: Jacc focus seminar 1/9. J Am Coll Cardiol. 2021;78:2460–70.PubMedCrossRef
26.
go back to reference Chrysaidou K, Chainoglou A, Karava V, Dotis J, Printza N, Stabouli S. Secondary hypertension in children and adolescents: novel insights. Curr Hypertens Rev. 2020;16:37–44.PubMedCrossRef Chrysaidou K, Chainoglou A, Karava V, Dotis J, Printza N, Stabouli S. Secondary hypertension in children and adolescents: novel insights. Curr Hypertens Rev. 2020;16:37–44.PubMedCrossRef
27.
go back to reference Hartung EA, Guay-Woodford LM. Autosomal recessive polycystic kidney disease: a hepatorenal fibrocystic disorder with pleiotropic effects. Pediatrics. 2014;134:e833-845.PubMedPubMedCentralCrossRef Hartung EA, Guay-Woodford LM. Autosomal recessive polycystic kidney disease: a hepatorenal fibrocystic disorder with pleiotropic effects. Pediatrics. 2014;134:e833-845.PubMedPubMedCentralCrossRef
28.
go back to reference Narula N, Kadian-Dodov D, Olin JW. Fibromuscular dysplasia: contemporary concepts and future directions. Prog Cardiovasc Dis. 2018;60:580–5.PubMedCrossRef Narula N, Kadian-Dodov D, Olin JW. Fibromuscular dysplasia: contemporary concepts and future directions. Prog Cardiovasc Dis. 2018;60:580–5.PubMedCrossRef
29.
go back to reference Hendricks NJ, Matsumoto AH, Angle JF, Baheti A, Sabri SS, Park AW, et al. Is fibromuscular dysplasia underdiagnosed? A comparison of the prevalence of FMD seen in coral trial participants versus a single institution population of renal donor candidates. Vasc Med. 2014;19:363–7.PubMedCrossRef Hendricks NJ, Matsumoto AH, Angle JF, Baheti A, Sabri SS, Park AW, et al. Is fibromuscular dysplasia underdiagnosed? A comparison of the prevalence of FMD seen in coral trial participants versus a single institution population of renal donor candidates. Vasc Med. 2014;19:363–7.PubMedCrossRef
30.
31.
go back to reference Bubach S, De Mola CL, Hardy R, Dreyfus J, Santos AC, Horta BL. Early menarche and blood pressure in adulthood: systematic review and meta-analysis. J Public Health (Oxf). 2018;40:476–84.PubMedCrossRef Bubach S, De Mola CL, Hardy R, Dreyfus J, Santos AC, Horta BL. Early menarche and blood pressure in adulthood: systematic review and meta-analysis. J Public Health (Oxf). 2018;40:476–84.PubMedCrossRef
32.
go back to reference Wu CH, Chiu LT, Chang YJ, Lee CI, Lee MS, Lee TH, et al. Hypertension risk in young women with polycystic ovary syndrome: a nationwide population-based cohort study. Front Med (Lausanne). 2020;7:574651.PubMedCrossRef Wu CH, Chiu LT, Chang YJ, Lee CI, Lee MS, Lee TH, et al. Hypertension risk in young women with polycystic ovary syndrome: a nationwide population-based cohort study. Front Med (Lausanne). 2020;7:574651.PubMedCrossRef
33.
34.
go back to reference Lenders JW, Pacak K, Walther MM, Linehan WM, Mannelli M, Friberg P, et al. Biochemical diagnosis of pheochromocytoma: which test is best? JAMA. 2002;287:1427–34.PubMedCrossRef Lenders JW, Pacak K, Walther MM, Linehan WM, Mannelli M, Friberg P, et al. Biochemical diagnosis of pheochromocytoma: which test is best? JAMA. 2002;287:1427–34.PubMedCrossRef
36.
go back to reference Lin AE, Prakash SK, Andersen NH, Viuff MH, Levitsky LL, Rivera-Davila M, et al. Recognition and management of adults with turner syndrome: from the transition of adolescence through the senior years. Am J Med Genet A. 2019;179:1987–2033.PubMedCrossRef Lin AE, Prakash SK, Andersen NH, Viuff MH, Levitsky LL, Rivera-Davila M, et al. Recognition and management of adults with turner syndrome: from the transition of adolescence through the senior years. Am J Med Genet A. 2019;179:1987–2033.PubMedCrossRef
37.
go back to reference Lacro RV, Jones KL, Benirschke K. Coarctation of the aorta in turner syndrome: a pathologic study of fetuses with nuchal cystic hygromas, hydrops fetalis, and female genitalia. Pediatrics. 1988;81:445–51.PubMed Lacro RV, Jones KL, Benirschke K. Coarctation of the aorta in turner syndrome: a pathologic study of fetuses with nuchal cystic hygromas, hydrops fetalis, and female genitalia. Pediatrics. 1988;81:445–51.PubMed
38.
go back to reference Chen X, Wang Y. Tracking of blood pressure from childhood to adulthood: a systematic review and meta-regression analysis. Circulation. 2008;117:3171–80.PubMedPubMedCentralCrossRef Chen X, Wang Y. Tracking of blood pressure from childhood to adulthood: a systematic review and meta-regression analysis. Circulation. 2008;117:3171–80.PubMedPubMedCentralCrossRef
39.
go back to reference Colafella KMM, Denton KM. Sex-specific differences in hypertension and associated cardiovascular disease. Nat Rev Nephrol. 2018;14:185–201.PubMedCrossRef Colafella KMM, Denton KM. Sex-specific differences in hypertension and associated cardiovascular disease. Nat Rev Nephrol. 2018;14:185–201.PubMedCrossRef
40.
go back to reference Viera AJ, Neutze DM. Diagnosis of secondary hypertension: an age-based approach. Am Fam Physician. 2010;82:1471–8.PubMed Viera AJ, Neutze DM. Diagnosis of secondary hypertension: an age-based approach. Am Fam Physician. 2010;82:1471–8.PubMed
41.
go back to reference Wenger NK, Arnold A, Bairey Merz CN, Cooper-DeHoff RM, Ferdinand KC, Fleg JL, et al. Hypertension across a woman’s life cycle. J Am Coll Cardiol. 2018;71:1797–813.PubMedPubMedCentralCrossRef Wenger NK, Arnold A, Bairey Merz CN, Cooper-DeHoff RM, Ferdinand KC, Fleg JL, et al. Hypertension across a woman’s life cycle. J Am Coll Cardiol. 2018;71:1797–813.PubMedPubMedCentralCrossRef
42.
go back to reference Pappadis SL, Somers MJ. Hypertension in adolescents: a review of diagnosis and management. Curr Opin Pediatr. 2003;15:370–8.PubMedCrossRef Pappadis SL, Somers MJ. Hypertension in adolescents: a review of diagnosis and management. Curr Opin Pediatr. 2003;15:370–8.PubMedCrossRef
43.
go back to reference Oparil S. Hypertension and oral contraceptives. J Cardiovasc Med. 1981;6(381):384–7. Oparil S. Hypertension and oral contraceptives. J Cardiovasc Med. 1981;6(381):384–7.
44.
go back to reference Bulletins—Gynecology. Acog practice bulletin no. 206: Use of hormonal contraception in women with coexisting medical conditions. Obstet Gynecol. 2019;133:e128–50.CrossRef Bulletins—Gynecology. Acog practice bulletin no. 206: Use of hormonal contraception in women with coexisting medical conditions. Obstet Gynecol. 2019;133:e128–50.CrossRef
45.
go back to reference Wang W, Xie X, Yuan T, Wang Y, Zhao F, Zhou Z, et al. Epidemiological trends of maternal hypertensive disorders of pregnancy at the global, regional, and national levels: a population-based study. BMC Pregnancy Childbirth. 2021;21:364.PubMedPubMedCentralCrossRef Wang W, Xie X, Yuan T, Wang Y, Zhao F, Zhou Z, et al. Epidemiological trends of maternal hypertensive disorders of pregnancy at the global, regional, and national levels: a population-based study. BMC Pregnancy Childbirth. 2021;21:364.PubMedPubMedCentralCrossRef
46.
go back to reference Program NHBPE. Report of the national high blood pressure education program working group on high blood pressure in pregnancy. Am J Bbstet Gynecol. 2000;183(1):s1–s22. Program NHBPE. Report of the national high blood pressure education program working group on high blood pressure in pregnancy. Am J Bbstet Gynecol. 2000;183(1):s1–s22.
47.
go back to reference American College of Obstetricians and Gynecologists. ACOG practice bulletin no. 202: gestational hypertension and preeclampsia. Obstet Gynecol. 2019;133(1);e1–e25. American College of Obstetricians and Gynecologists. ACOG practice bulletin no. 202: gestational hypertension and preeclampsia. Obstet Gynecol. 2019;133(1);e1–e25.
48.
go back to reference Visintin C, Mugglestone MA, Almerie MQ, Nherera LM, James D, Walkinshaw S, et al. Management of hypertensive disorders during pregnancy: summary of nice guidance. BMJ. 2010;341:c2207.PubMedCrossRef Visintin C, Mugglestone MA, Almerie MQ, Nherera LM, James D, Walkinshaw S, et al. Management of hypertensive disorders during pregnancy: summary of nice guidance. BMJ. 2010;341:c2207.PubMedCrossRef
49.
go back to reference Bernstein PS, Martin JN, Barton JR, Shields LE, Druzin ML, Scavone BM, et al. Consensus bundle on severe hypertension during pregnancy and the postpartum period. J Obstet Gynecol Neonatal Nurs. 2017;46:776–87.PubMedCrossRef Bernstein PS, Martin JN, Barton JR, Shields LE, Druzin ML, Scavone BM, et al. Consensus bundle on severe hypertension during pregnancy and the postpartum period. J Obstet Gynecol Neonatal Nurs. 2017;46:776–87.PubMedCrossRef
50.
go back to reference Bulletins Obstetrics ACoOaGCoP. Acog practice bulletin no. 203: Chronic hypertension in pregnancy. Obstet Gynecol. 2019;133:e26–50.CrossRef Bulletins Obstetrics ACoOaGCoP. Acog practice bulletin no. 203: Chronic hypertension in pregnancy. Obstet Gynecol. 2019;133:e26–50.CrossRef
51.
go back to reference Whelton PK, Carey RM, Aronow WS, Casey DE, Collins KJ, Dennison Himmelfarb C, et al. 2017 acc/aha/aapa/abc/acpm/ags/apha/ash/aspc/nma/pcna guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: executive summary: a report of the American College Of Cardiology/American Heart Association Task Force on clinical practice guidelines. Circulation. 2018;138:e426–83.PubMed Whelton PK, Carey RM, Aronow WS, Casey DE, Collins KJ, Dennison Himmelfarb C, et al. 2017 acc/aha/aapa/abc/acpm/ags/apha/ash/aspc/nma/pcna guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: executive summary: a report of the American College Of Cardiology/American Heart Association Task Force on clinical practice guidelines. Circulation. 2018;138:e426–83.PubMed
52.
go back to reference Regitz-Zagrosek V, Roos-Hesselink JW, Bauersachs J, Blomström-Lundqvist C, Cífková R, De Bonis M, et al. 2018 esc guidelines for the management of cardiovascular diseases during pregnancy. Eur Heart J. 2018;39:3165–241.PubMedCrossRef Regitz-Zagrosek V, Roos-Hesselink JW, Bauersachs J, Blomström-Lundqvist C, Cífková R, De Bonis M, et al. 2018 esc guidelines for the management of cardiovascular diseases during pregnancy. Eur Heart J. 2018;39:3165–241.PubMedCrossRef
53.
go back to reference Butalia S, Audibert F, Côté AM, Firoz T, Logan AG, Magee LA, et al. Hypertension Canada’s 2018 guidelines for the management of hypertension in pregnancy. Can J Cardiol. 2018;34:526–31.PubMedCrossRef Butalia S, Audibert F, Côté AM, Firoz T, Logan AG, Magee LA, et al. Hypertension Canada’s 2018 guidelines for the management of hypertension in pregnancy. Can J Cardiol. 2018;34:526–31.PubMedCrossRef
54.
go back to reference Magee LA, Pels A, Helewa M, Rey E, von Dadelszen P. Group CHDoPW: Diagnosis, evaluation, and management of the hypertensive disorders of pregnancy: Executive summary. J Obstet Gynaecol Can. 2014;36:416–41.PubMedCrossRef Magee LA, Pels A, Helewa M, Rey E, von Dadelszen P. Group CHDoPW: Diagnosis, evaluation, and management of the hypertensive disorders of pregnancy: Executive summary. J Obstet Gynaecol Can. 2014;36:416–41.PubMedCrossRef
55.
go back to reference Boesen EI. Consequences of in-utero exposure to antihypertensive medication: the search for definitive answers continues. J Hypertens. 2017;35:2161–4.PubMedCrossRef Boesen EI. Consequences of in-utero exposure to antihypertensive medication: the search for definitive answers continues. J Hypertens. 2017;35:2161–4.PubMedCrossRef
56.
go back to reference Fitton CA, Steiner MFC, Aucott L, Pell JP, Mackay DF, Fleming M, et al. In-utero exposure to antihypertensive medication and neonatal and child health outcomes: a systematic review. J Hypertens. 2017;35:2123–37.PubMedPubMedCentralCrossRef Fitton CA, Steiner MFC, Aucott L, Pell JP, Mackay DF, Fleming M, et al. In-utero exposure to antihypertensive medication and neonatal and child health outcomes: a systematic review. J Hypertens. 2017;35:2123–37.PubMedPubMedCentralCrossRef
58.
go back to reference Duley L, Meher S, Hunter KE, Seidler AL, Askie LM. Antiplatelet agents for preventing pre-eclampsia and its complications. Cochrane Database Syst Rev. 2019;2019. Duley L, Meher S, Hunter KE, Seidler AL, Askie LM. Antiplatelet agents for preventing pre-eclampsia and its complications. Cochrane Database Syst Rev. 2019;2019.
59.
go back to reference Roberge S, Nicolaides K, Demers S, Hyett J, Chaillet N, Bujold E. The role of aspirin dose on the prevention of preeclampsia and fetal growth restriction: systematic review and meta-analysis. Am J Obstet Gynecol. 2017;216:110-120.e116.PubMedCrossRef Roberge S, Nicolaides K, Demers S, Hyett J, Chaillet N, Bujold E. The role of aspirin dose on the prevention of preeclampsia and fetal growth restriction: systematic review and meta-analysis. Am J Obstet Gynecol. 2017;216:110-120.e116.PubMedCrossRef
61.
go back to reference •• Tita AT, Szychowski JM, Boggess K, Dugoff L, Sibai B, Lawrence K, et al. Treatment for mild chronic hypertension during pregnancy. N Engl J Med. 2022. This article reports the results of a randomized controlled study on the effectiveness of treatment of mild chronic hypertension in pregnant women. •• Tita AT, Szychowski JM, Boggess K, Dugoff L, Sibai B, Lawrence K, et al. Treatment for mild chronic hypertension during pregnancy. N Engl J Med. 2022. This article reports the results of a randomized controlled study on the effectiveness of treatment of mild chronic hypertension in pregnant women.
62.
go back to reference Mosca L, Benjamin EJ, Berra K, Bezanson JL, Dolor RJ, Lloyd-Jones DM, et al. Effectiveness-based guidelines for the prevention of cardiovascular disease in women–2011 update: a guideline from the American Heart Association. J Am Coll Cardiol. 2011;57:1404–23.PubMedPubMedCentralCrossRef Mosca L, Benjamin EJ, Berra K, Bezanson JL, Dolor RJ, Lloyd-Jones DM, et al. Effectiveness-based guidelines for the prevention of cardiovascular disease in women–2011 update: a guideline from the American Heart Association. J Am Coll Cardiol. 2011;57:1404–23.PubMedPubMedCentralCrossRef
63.
go back to reference Bushnell C, McCullough LD, Awad IA, Chireau MV, Fedder WN, Furie KL, et al. Nursing CoCaS, Cardiology CoC, Prevention CoEa, Research CfHBP: guidelines for the prevention of stroke in women: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2014;45:1545–88.PubMedCrossRef Bushnell C, McCullough LD, Awad IA, Chireau MV, Fedder WN, Furie KL, et al. Nursing CoCaS, Cardiology CoC, Prevention CoEa, Research CfHBP: guidelines for the prevention of stroke in women: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2014;45:1545–88.PubMedCrossRef
64.
go back to reference Mongraw-Chaffin ML, Cirillo PM, Cohn BA. Preeclampsia and cardiovascular disease death: prospective evidence from the child health and development studies cohort. Hypertension. 2010;56:166–71.PubMedCrossRef Mongraw-Chaffin ML, Cirillo PM, Cohn BA. Preeclampsia and cardiovascular disease death: prospective evidence from the child health and development studies cohort. Hypertension. 2010;56:166–71.PubMedCrossRef
65.
go back to reference Benjamin EJ, Blaha MJ, Chiuve SE, Cushman M, Das SR, Deo R, et al. Subcommittee AHASCaSS: Heart Disease and Stroke Statistics-2017 update: a report from the American Heart Association. Circulation. 2017;135:e146–603.PubMedPubMedCentralCrossRef Benjamin EJ, Blaha MJ, Chiuve SE, Cushman M, Das SR, Deo R, et al. Subcommittee AHASCaSS: Heart Disease and Stroke Statistics-2017 update: a report from the American Heart Association. Circulation. 2017;135:e146–603.PubMedPubMedCentralCrossRef
66.
go back to reference Martins D, Nelson K, Pan D, Tareen N, Norris K. The effect of gender on age-related blood pressure changes and the prevalence of isolated systolic hypertension among older adults: data from NHANES III. J Gend Specif Med. 2001;4(10–13):20.PubMed Martins D, Nelson K, Pan D, Tareen N, Norris K. The effect of gender on age-related blood pressure changes and the prevalence of isolated systolic hypertension among older adults: data from NHANES III. J Gend Specif Med. 2001;4(10–13):20.PubMed
67.
go back to reference Staessen JA, Ginocchio G, Thijs L, Fagard R. Conventional and ambulatory blood pressure and menopause in a prospective population study. J Hum Hypertens. 1997;11:507–14.PubMedCrossRef Staessen JA, Ginocchio G, Thijs L, Fagard R. Conventional and ambulatory blood pressure and menopause in a prospective population study. J Hum Hypertens. 1997;11:507–14.PubMedCrossRef
68.
go back to reference Casiglia E, d’Este D, Ginocchio G, Colangeli G, Onesto C, Tramontin P, et al. Lack of influence of menopause on blood pressure and cardiovascular risk profile: a 16-year longitudinal study concerning a cohort of 568 women. J Hypertens. 1996;14:729–36.PubMedCrossRef Casiglia E, d’Este D, Ginocchio G, Colangeli G, Onesto C, Tramontin P, et al. Lack of influence of menopause on blood pressure and cardiovascular risk profile: a 16-year longitudinal study concerning a cohort of 568 women. J Hypertens. 1996;14:729–36.PubMedCrossRef
69.
go back to reference Clarkson TB. Estrogen effects on arteries vary with stage of reproductive life and extent of subclinical atherosclerosis progression. Menopause. 2007;14:373–84.PubMedCrossRef Clarkson TB. Estrogen effects on arteries vary with stage of reproductive life and extent of subclinical atherosclerosis progression. Menopause. 2007;14:373–84.PubMedCrossRef
70.
go back to reference Meyer MR, Haas E, Barton M. Gender differences of cardiovascular disease: new perspectives for estrogen receptor signaling. Hypertension. 2006;47:1019–26.PubMedCrossRef Meyer MR, Haas E, Barton M. Gender differences of cardiovascular disease: new perspectives for estrogen receptor signaling. Hypertension. 2006;47:1019–26.PubMedCrossRef
71.
go back to reference Levy D, DeStefano AL, Larson MG, O’Donnell CJ, Lifton RP, Gavras H, et al. Evidence for a gene influencing blood pressure on chromosome 17. Genome scan linkage results for longitudinal blood pressure phenotypes in subjects from the Framingham Heart Study. Hypertension. 2000;36:477–83.PubMedCrossRef Levy D, DeStefano AL, Larson MG, O’Donnell CJ, Lifton RP, Gavras H, et al. Evidence for a gene influencing blood pressure on chromosome 17. Genome scan linkage results for longitudinal blood pressure phenotypes in subjects from the Framingham Heart Study. Hypertension. 2000;36:477–83.PubMedCrossRef
72.
go back to reference Coylewright M, Reckelhoff JF, Ouyang P. Menopause and hypertension: an age-old debate. Hypertension. 2008;51:952–9.PubMedCrossRef Coylewright M, Reckelhoff JF, Ouyang P. Menopause and hypertension: an age-old debate. Hypertension. 2008;51:952–9.PubMedCrossRef
73.
go back to reference Rana BK, Insel PA, Payne SH, Abel K, Beutler E, Ziegler MG, et al. Population-based sample reveals gene-gender interactions in blood pressure in White Americans. Hypertension. 2007;49:96–106.PubMedCrossRef Rana BK, Insel PA, Payne SH, Abel K, Beutler E, Ziegler MG, et al. Population-based sample reveals gene-gender interactions in blood pressure in White Americans. Hypertension. 2007;49:96–106.PubMedCrossRef
74.
go back to reference Taddei S, Virdis A, Ghiadoni L, Mattei P, Sudano I, Bernini G, et al. Menopause is associated with endothelial dysfunction in women. Hypertension. 1996;28:576–82.PubMedCrossRef Taddei S, Virdis A, Ghiadoni L, Mattei P, Sudano I, Bernini G, et al. Menopause is associated with endothelial dysfunction in women. Hypertension. 1996;28:576–82.PubMedCrossRef
75.
go back to reference Rossi R, Chiurlia E, Nuzzo A, Cioni E, Origliani G, Modena MG. Flow-mediated vasodilation and the risk of developing hypertension in healthy postmenopausal women. J Am Coll Cardiol. 2004;44:1636–40.PubMedCrossRef Rossi R, Chiurlia E, Nuzzo A, Cioni E, Origliani G, Modena MG. Flow-mediated vasodilation and the risk of developing hypertension in healthy postmenopausal women. J Am Coll Cardiol. 2004;44:1636–40.PubMedCrossRef
76.
go back to reference Pechère-Bertschi A, Burnier M. Female sex hormones, salt, and blood pressure regulation. Am J Hypertens. 2004;17:994–1001.PubMedCrossRef Pechère-Bertschi A, Burnier M. Female sex hormones, salt, and blood pressure regulation. Am J Hypertens. 2004;17:994–1001.PubMedCrossRef
79.
go back to reference Gierach GL, Johnson BD, Bairey Merz CN, Kelsey SF, Bittner V, Olson MB, et al. Hypertension, menopause, and coronary artery disease risk in the women’s ischemia syndrome evaluation (wise) study. J Am Coll Cardiol. 2006;47:S50-58.PubMedCrossRef Gierach GL, Johnson BD, Bairey Merz CN, Kelsey SF, Bittner V, Olson MB, et al. Hypertension, menopause, and coronary artery disease risk in the women’s ischemia syndrome evaluation (wise) study. J Am Coll Cardiol. 2006;47:S50-58.PubMedCrossRef
80.
go back to reference Oparil S. Women and hypertension: what did we learn from the women’s health initiative? Cardiol Rev. 2006;14:267–75.PubMedCrossRef Oparil S. Women and hypertension: what did we learn from the women’s health initiative? Cardiol Rev. 2006;14:267–75.PubMedCrossRef
81.
go back to reference Stuenkel CA, Davis SR, Gompel A, Lumsden MA, Murad MH, Pinkerton JV, et al. Treatment of symptoms of the menopause: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2015;100:3975–4011.PubMedCrossRef Stuenkel CA, Davis SR, Gompel A, Lumsden MA, Murad MH, Pinkerton JV, et al. Treatment of symptoms of the menopause: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2015;100:3975–4011.PubMedCrossRef
82.
go back to reference Chiu CL, Lujic S, Thornton C, O’Loughlin A, Makris A, Hennessy A, et al. Menopausal hormone therapy is associated with having high blood pressure in postmenopausal women: Observational cohort study. PLoS ONE. 2012;7:e40260.PubMedPubMedCentralCrossRef Chiu CL, Lujic S, Thornton C, O’Loughlin A, Makris A, Hennessy A, et al. Menopausal hormone therapy is associated with having high blood pressure in postmenopausal women: Observational cohort study. PLoS ONE. 2012;7:e40260.PubMedPubMedCentralCrossRef
83.
go back to reference • Madika AL, MacDonald CJ, Fournier A, Mounier-Vehier C, Béraud G, Boutron-Ruault MC. Menopausal hormone therapy and risk of incident hypertension: role of the route of estrogen administration and progestogens in the e3n cohort. Menopause. 2021;28:1204–8. This is an observational cohort study that assessed effect of different formulations of menopausal hormone therapy on incident hypertension among menopausal women.PubMedCrossRef • Madika AL, MacDonald CJ, Fournier A, Mounier-Vehier C, Béraud G, Boutron-Ruault MC. Menopausal hormone therapy and risk of incident hypertension: role of the route of estrogen administration and progestogens in the e3n cohort. Menopause. 2021;28:1204–8. This is an observational cohort study that assessed effect of different formulations of menopausal hormone therapy on incident hypertension among menopausal women.PubMedCrossRef
84.
go back to reference • Yoon BK, Sung J, Song YM, Kim SM, Son KA, Yoo JH, et al. Effects of menopausal hormone therapy on ambulatory blood pressure and arterial stiffness in postmenopausal Korean women with grade 1 hypertension: a randomized, placebo-controlled trial. Clin Hypertens. 2021;27:18. This was a randomized placebo controlled trial that assessed the impact of micronized progesterone combined estradiol gel on hemodynamics in postmenopausal women with grade 1 hypertension.PubMedPubMedCentralCrossRef • Yoon BK, Sung J, Song YM, Kim SM, Son KA, Yoo JH, et al. Effects of menopausal hormone therapy on ambulatory blood pressure and arterial stiffness in postmenopausal Korean women with grade 1 hypertension: a randomized, placebo-controlled trial. Clin Hypertens. 2021;27:18. This was a randomized placebo controlled trial that assessed the impact of micronized progesterone combined estradiol gel on hemodynamics in postmenopausal women with grade 1 hypertension.PubMedPubMedCentralCrossRef
85.
go back to reference Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, Stefanick ML, et al. Investigators WGftWsHI: risks and benefits of estrogen plus progestin in healthy postmenopausal women: Principal results from the women’s health initiative randomized controlled trial. JAMA. 2002;288:321–33.PubMedCrossRef Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, Stefanick ML, et al. Investigators WGftWsHI: risks and benefits of estrogen plus progestin in healthy postmenopausal women: Principal results from the women’s health initiative randomized controlled trial. JAMA. 2002;288:321–33.PubMedCrossRef
86.
go back to reference Mosca L, Collins P, Herrington DM, Mendelsohn ME, Pasternak RC, Robertson RM, et al. Hormone replacement therapy and cardiovascular disease: a statement for healthcare professionals from the American Heart Association. Circulation. 2001;104:499–503.PubMedCrossRef Mosca L, Collins P, Herrington DM, Mendelsohn ME, Pasternak RC, Robertson RM, et al. Hormone replacement therapy and cardiovascular disease: a statement for healthcare professionals from the American Heart Association. Circulation. 2001;104:499–503.PubMedCrossRef
87.
go back to reference Muntner P, Carey RM, Gidding S, Jones DW, Taler SJ, Wright JT, et al. Potential us population impact of the 2017 acc/aha high blood pressure guideline. Circulation. 2018;137:109–18.PubMedCrossRef Muntner P, Carey RM, Gidding S, Jones DW, Taler SJ, Wright JT, et al. Potential us population impact of the 2017 acc/aha high blood pressure guideline. Circulation. 2018;137:109–18.PubMedCrossRef
88.
go back to reference Bundy JD, Mills KT, Chen J, Li C, Greenland P, He J. Estimating the association of the 2017 and 2014 hypertension guidelines with cardiovascular events and deaths in us adults: an analysis of national data. JAMA Cardiol. 2018;3:572–81.PubMedPubMedCentralCrossRef Bundy JD, Mills KT, Chen J, Li C, Greenland P, He J. Estimating the association of the 2017 and 2014 hypertension guidelines with cardiovascular events and deaths in us adults: an analysis of national data. JAMA Cardiol. 2018;3:572–81.PubMedPubMedCentralCrossRef
89.
go back to reference Benjamin EJ, Muntner P, Alonso A, Bittencourt MS, Callaway CW, Carson AP, et al. Subcommittee AHACoEaPSCaSS: Heart Disease and Stroke Statistics-2019 update: a report from the American Heart Association. Circulation. 2019;139:e56–528.PubMedCrossRef Benjamin EJ, Muntner P, Alonso A, Bittencourt MS, Callaway CW, Carson AP, et al. Subcommittee AHACoEaPSCaSS: Heart Disease and Stroke Statistics-2019 update: a report from the American Heart Association. Circulation. 2019;139:e56–528.PubMedCrossRef
90.
go back to reference Celermajer DS, Sorensen KE, Spiegelhalter DJ, Georgakopoulos D, Robinson J, Deanfield JE. Aging is associated with endothelial dysfunction in healthy men years before the age-related decline in women. J Am Coll Cardiol. 1994;24:471–6.PubMedCrossRef Celermajer DS, Sorensen KE, Spiegelhalter DJ, Georgakopoulos D, Robinson J, Deanfield JE. Aging is associated with endothelial dysfunction in healthy men years before the age-related decline in women. J Am Coll Cardiol. 1994;24:471–6.PubMedCrossRef
92.
go back to reference Elias PK, Elias MF, Robbins MA, Budge MM. Blood pressure-related cognitive decline: does age make a difference? Hypertension. 2004;44:631–6.PubMedCrossRef Elias PK, Elias MF, Robbins MA, Budge MM. Blood pressure-related cognitive decline: does age make a difference? Hypertension. 2004;44:631–6.PubMedCrossRef
93.
go back to reference Qiu C, Winblad B, Fratiglioni L. The age-dependent relation of blood pressure to cognitive function and dementia. Lancet Neurol. 2005;4:487–99.PubMedCrossRef Qiu C, Winblad B, Fratiglioni L. The age-dependent relation of blood pressure to cognitive function and dementia. Lancet Neurol. 2005;4:487–99.PubMedCrossRef
94.
go back to reference de Bruijn RF, Bos MJ, Portegies ML, Hofman A, Franco OH, Koudstaal PJ, et al. The potential for prevention of dementia across two decades: the prospective, population-based rotterdam study. BMC Med. 2015;13:132.PubMedPubMedCentralCrossRef de Bruijn RF, Bos MJ, Portegies ML, Hofman A, Franco OH, Koudstaal PJ, et al. The potential for prevention of dementia across two decades: the prospective, population-based rotterdam study. BMC Med. 2015;13:132.PubMedPubMedCentralCrossRef
95.
go back to reference Danaei G, Ding EL, Mozaffarian D, Taylor B, Rehm J, Murray CJ, et al. The preventable causes of death in the United States: comparative risk assessment of dietary, lifestyle, and metabolic risk factors. PLoS Med. 2009;6:e1000058.PubMedPubMedCentralCrossRef Danaei G, Ding EL, Mozaffarian D, Taylor B, Rehm J, Murray CJ, et al. The preventable causes of death in the United States: comparative risk assessment of dietary, lifestyle, and metabolic risk factors. PLoS Med. 2009;6:e1000058.PubMedPubMedCentralCrossRef
96.
go back to reference Shep Cooperative Research Group. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the systolic hypertension in the elderly program (shep). JAMA. 1991;265:3255–64.CrossRef Shep Cooperative Research Group. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the systolic hypertension in the elderly program (shep). JAMA. 1991;265:3255–64.CrossRef
97.
go back to reference Lewis CE, Fine LJ, Beddhu S, Cheung AK, Cushman WC, Cutler JA, et al. Final report of a trial of intensive versus standard blood-pressure control. N Engl J Med. 2021;384:1921–30.PubMedCrossRef Lewis CE, Fine LJ, Beddhu S, Cheung AK, Cushman WC, Cutler JA, et al. Final report of a trial of intensive versus standard blood-pressure control. N Engl J Med. 2021;384:1921–30.PubMedCrossRef
98.
go back to reference Staessen JA, Fagard R, Thijs L, Celis H, Arabidze GG, Birkenhäger WH, et al. Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. The systolic hypertension in Europe (Syst-Eur) trial investigators. Lancet. 1997;350:757–64.PubMedCrossRef Staessen JA, Fagard R, Thijs L, Celis H, Arabidze GG, Birkenhäger WH, et al. Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. The systolic hypertension in Europe (Syst-Eur) trial investigators. Lancet. 1997;350:757–64.PubMedCrossRef
99.
go back to reference Zhang W, Zhang S, Deng Y, Wu S, Ren J, Sun G, et al. Trial of intensive blood-pressure control in older patients with hypertension. N Engl J Med. 2021;385:1268–79.PubMedCrossRef Zhang W, Zhang S, Deng Y, Wu S, Ren J, Sun G, et al. Trial of intensive blood-pressure control in older patients with hypertension. N Engl J Med. 2021;385:1268–79.PubMedCrossRef
100.
go back to reference Williamson JD, Supiano MA, Applegate WB, Berlowitz DR, Campbell RC, Chertow GM, et al. Intensive vs standard blood pressure control and cardiovascular disease outcomes in adults aged ≥75 years: a randomized clinical trial. JAMA. 2016;315:2673–82.PubMedPubMedCentralCrossRef Williamson JD, Supiano MA, Applegate WB, Berlowitz DR, Campbell RC, Chertow GM, et al. Intensive vs standard blood pressure control and cardiovascular disease outcomes in adults aged ≥75 years: a randomized clinical trial. JAMA. 2016;315:2673–82.PubMedPubMedCentralCrossRef
101.
go back to reference Yoon SS, Carroll MD, Fryar CD. Hypertension prevalence and control among adults: United States, 2011–2014. NCHS Data Brief. 2015:1–8. Yoon SS, Carroll MD, Fryar CD. Hypertension prevalence and control among adults: United States, 2011–2014. NCHS Data Brief. 2015:1–8.
102.
go back to reference Gu A, Yue Y, Desai RP, Argulian E. Racial and ethnic differences in antihypertensive medication use and blood pressure control among us adults with hypertension: the national health and nutrition examination survey, 2003 to 2012. Circ Cardiovasc Qual Outcomes. 2017;10. Gu A, Yue Y, Desai RP, Argulian E. Racial and ethnic differences in antihypertensive medication use and blood pressure control among us adults with hypertension: the national health and nutrition examination survey, 2003 to 2012. Circ Cardiovasc Qual Outcomes. 2017;10.
103.
go back to reference Wang X, Poole JC, Treiber FA, Harshfield GA, Hanevold CD, Snieder H. Ethnic and gender differences in ambulatory blood pressure trajectories: results from a 15-year longitudinal study in youth and young adults. Circulation. 2006;114:2780–7.PubMedCrossRef Wang X, Poole JC, Treiber FA, Harshfield GA, Hanevold CD, Snieder H. Ethnic and gender differences in ambulatory blood pressure trajectories: results from a 15-year longitudinal study in youth and young adults. Circulation. 2006;114:2780–7.PubMedCrossRef
104.
go back to reference Fumo MT, Teeger S, Lang RM, Bednarz J, Sareli P, Murphy MB. Diurnal blood pressure variation and cardiac mass in American Blacks and Whites and South African Blacks. Am J Hypertens. 1992;5:111–6.PubMedCrossRef Fumo MT, Teeger S, Lang RM, Bednarz J, Sareli P, Murphy MB. Diurnal blood pressure variation and cardiac mass in American Blacks and Whites and South African Blacks. Am J Hypertens. 1992;5:111–6.PubMedCrossRef
105.
go back to reference Stevens J, Truesdale KP, Katz EG, Cai J. Impact of body mass index on incident hypertension and diabetes in Chinese Asians, American Whites, and American Blacks: the People’s Republic of China study and the atherosclerosis risk in communities study. Am J Epidemiol. 2008;167:1365–74.PubMedCrossRef Stevens J, Truesdale KP, Katz EG, Cai J. Impact of body mass index on incident hypertension and diabetes in Chinese Asians, American Whites, and American Blacks: the People’s Republic of China study and the atherosclerosis risk in communities study. Am J Epidemiol. 2008;167:1365–74.PubMedCrossRef
106.
go back to reference Andrew ME, Jones DW, Wofford MR, Wyatt SB, Schreiner PJ, Brown CA, et al. Ethnicity and unprovoked hypokalemia in the atherosclerosis risk in communities study. Am J Hypertens. 2002;15:594–9.PubMedCrossRef Andrew ME, Jones DW, Wofford MR, Wyatt SB, Schreiner PJ, Brown CA, et al. Ethnicity and unprovoked hypokalemia in the atherosclerosis risk in communities study. Am J Hypertens. 2002;15:594–9.PubMedCrossRef
107.
go back to reference Wright JT, Rahman M, Scarpa A, Fatholahi M, Griffin V, Jean-Baptiste R, et al. Determinants of salt sensitivity in black and white normotensive and hypertensive women. Hypertension. 2003;42:1087–92.PubMedCrossRef Wright JT, Rahman M, Scarpa A, Fatholahi M, Griffin V, Jean-Baptiste R, et al. Determinants of salt sensitivity in black and white normotensive and hypertensive women. Hypertension. 2003;42:1087–92.PubMedCrossRef
108.
go back to reference Sorlie PD, Allison MA, Avilés-Santa ML, Cai J, Daviglus ML, Howard AG, et al. Prevalence of hypertension, awareness, treatment, and control in the Hispanic Community Health Study/Study of Latinos. Am J Hypertens. 2014;27:793–800.PubMedPubMedCentralCrossRef Sorlie PD, Allison MA, Avilés-Santa ML, Cai J, Daviglus ML, Howard AG, et al. Prevalence of hypertension, awareness, treatment, and control in the Hispanic Community Health Study/Study of Latinos. Am J Hypertens. 2014;27:793–800.PubMedPubMedCentralCrossRef
109.
go back to reference Fryar CD, Ostchega Y, Hales CM, Zhang G, Kruszon-Moran D. Hypertension prevalence and control among adults: United States, 2015–2016. NCHS Data Brief. 2017:1–8. Fryar CD, Ostchega Y, Hales CM, Zhang G, Kruszon-Moran D. Hypertension prevalence and control among adults: United States, 2015–2016. NCHS Data Brief. 2017:1–8.
110.
go back to reference Foti K, Wang D, Appel LJ, Selvin E. Hypertension awareness, treatment, and control in us adults: trends in the hypertension control cascade by population subgroup (national health and nutrition examination survey, 1999–2016). Am J Epidemiol. 2019;188:2165–74.PubMedPubMedCentralCrossRef Foti K, Wang D, Appel LJ, Selvin E. Hypertension awareness, treatment, and control in us adults: trends in the hypertension control cascade by population subgroup (national health and nutrition examination survey, 1999–2016). Am J Epidemiol. 2019;188:2165–74.PubMedPubMedCentralCrossRef
111.
go back to reference Fuentes A, Ackermann RR, Athreya S, Bolnick D, Lasisi T, Lee SH, et al. Aapa statement on race and racism. Am J Phys Anthropol. 2019;169:400–2.PubMedCrossRef Fuentes A, Ackermann RR, Athreya S, Bolnick D, Lasisi T, Lee SH, et al. Aapa statement on race and racism. Am J Phys Anthropol. 2019;169:400–2.PubMedCrossRef
112.
go back to reference Leng B, Jin Y, Li G, Chen L, Jin N. Socioeconomic status and hypertension: a meta-analysis. J Hypertens. 2015;33:221–9.PubMedCrossRef Leng B, Jin Y, Li G, Chen L, Jin N. Socioeconomic status and hypertension: a meta-analysis. J Hypertens. 2015;33:221–9.PubMedCrossRef
113.
go back to reference Nachman D, Gilan A, Goldstein N, Constantini K, Littman R, Eisenkraft A, et al. 24-hour ambulatory blood pressure measurement using a novel non-invasive, cuff-less, wireless device. Am J Hypertens. 2021. Nachman D, Gilan A, Goldstein N, Constantini K, Littman R, Eisenkraft A, et al. 24-hour ambulatory blood pressure measurement using a novel non-invasive, cuff-less, wireless device. Am J Hypertens. 2021.
114.
go back to reference National Center for Health Statistics (U.S.). Health US, 2013: With special feature on, prescription drugs. Hyattsville MNCfHS, (U.S.), 2014. National Center for Health Statistics (U.S.). Health US, 2013: With special feature on, prescription drugs. Hyattsville MNCfHS, (U.S.), 2014.
115.
go back to reference Rodriguez CJ, Allison M, Daviglus ML, Isasi CR, Keller C, Leira EC, et al. Prevention AHACoEa, Cardiology AHACoC, Nursing AHACoCaS: Status of cardiovascular disease and stroke in Hispanics/Latinos in the United States: a science advisory from the American Heart Association. Circulation. 2014;130:593–625.PubMedPubMedCentralCrossRef Rodriguez CJ, Allison M, Daviglus ML, Isasi CR, Keller C, Leira EC, et al. Prevention AHACoEa, Cardiology AHACoC, Nursing AHACoCaS: Status of cardiovascular disease and stroke in Hispanics/Latinos in the United States: a science advisory from the American Heart Association. Circulation. 2014;130:593–625.PubMedPubMedCentralCrossRef
116.
go back to reference Cushman WC, Evans GW, Byington RP, Goff DC, Grimm RH, Cutler JA, et al. Effects of intensive blood-pressure control in type 2 diabetes mellitus. N Engl J Med. 2010;362:1575–85.PubMedCrossRef Cushman WC, Evans GW, Byington RP, Goff DC, Grimm RH, Cutler JA, et al. Effects of intensive blood-pressure control in type 2 diabetes mellitus. N Engl J Med. 2010;362:1575–85.PubMedCrossRef
117.
go back to reference Trial PHA. Major outcomes in high-Risk hypertensive patients. Jama. 2002;288(23):2981–97. Trial PHA. Major outcomes in high-Risk hypertensive patients. Jama. 2002;288(23):2981–97.
118.
go back to reference Kim EJ, Kim T, Paasche-Orlow MK, Rose AJ, Hanchate AD. Disparities in hypertension associated with limited English proficiency. J Gen Intern Med. 2017;32:632–9.PubMedPubMedCentralCrossRef Kim EJ, Kim T, Paasche-Orlow MK, Rose AJ, Hanchate AD. Disparities in hypertension associated with limited English proficiency. J Gen Intern Med. 2017;32:632–9.PubMedPubMedCentralCrossRef
119.
go back to reference Johnson RL, Roter D, Powe NR, Cooper LA. Patient race/ethnicity and quality of patient-physician communication during medical visits. Am J Public Health. 2004;94:2084–90.PubMedPubMedCentralCrossRef Johnson RL, Roter D, Powe NR, Cooper LA. Patient race/ethnicity and quality of patient-physician communication during medical visits. Am J Public Health. 2004;94:2084–90.PubMedPubMedCentralCrossRef
120.
go back to reference Cené CW, Roter D, Carson KA, Miller ER, Cooper LA. The effect of patient race and blood pressure control on patient-physician communication. J Gen Intern Med. 2009;24:1057–64.PubMedPubMedCentralCrossRef Cené CW, Roter D, Carson KA, Miller ER, Cooper LA. The effect of patient race and blood pressure control on patient-physician communication. J Gen Intern Med. 2009;24:1057–64.PubMedPubMedCentralCrossRef
121.
go back to reference Gerber LM, Mann SJ, McDonald MV, Chiu YL, Sridharan S, Feldman PH. Diuretic use in black patients with uncontrolled hypertension. Am J Hypertens. 2013;26:174–9.PubMedPubMedCentralCrossRef Gerber LM, Mann SJ, McDonald MV, Chiu YL, Sridharan S, Feldman PH. Diuretic use in black patients with uncontrolled hypertension. Am J Hypertens. 2013;26:174–9.PubMedPubMedCentralCrossRef
122.
go back to reference Fan AZ, Strasser SM, Zhang X, Fang J, Crawford CG. State socioeconomic indicators and self-reported hypertension among us adults, 2011 behavioral risk factor surveillance system. Prev Chronic Dis. 2015;12:E27.PubMedPubMedCentralCrossRef Fan AZ, Strasser SM, Zhang X, Fang J, Crawford CG. State socioeconomic indicators and self-reported hypertension among us adults, 2011 behavioral risk factor surveillance system. Prev Chronic Dis. 2015;12:E27.PubMedPubMedCentralCrossRef
123.
go back to reference Mahajan S, Caraballo C, Lu Y, Valero-Elizondo J, Massey D, Annapureddy AR, et al. Trends in differences in health status and health care access and affordability by race and ethnicity in the united states, 1999–2018. JAMA. 2021;326:637–48.PubMedPubMedCentralCrossRef Mahajan S, Caraballo C, Lu Y, Valero-Elizondo J, Massey D, Annapureddy AR, et al. Trends in differences in health status and health care access and affordability by race and ethnicity in the united states, 1999–2018. JAMA. 2021;326:637–48.PubMedPubMedCentralCrossRef
124.
go back to reference Tziomalos K, Giampatzis V, Baltatzi M, Efthymiou E, Psianou K, Papastergiou N, et al. Sex-specific differences in cardiovascular risk factors and blood pressure control in hypertensive patients. J Clin Hypertens (Greenwich). 2014;16:309–12.PubMedCrossRef Tziomalos K, Giampatzis V, Baltatzi M, Efthymiou E, Psianou K, Papastergiou N, et al. Sex-specific differences in cardiovascular risk factors and blood pressure control in hypertensive patients. J Clin Hypertens (Greenwich). 2014;16:309–12.PubMedCrossRef
125.
go back to reference Guirguis-Blake JM, Evans CV, Webber EM, Coppola EL, Perdue LA, Weyrich MS. Screening for hypertension in adults: updated evidence report and systematic review for the us preventive services task force. JAMA. 2021;325:1657–69.PubMedCrossRef Guirguis-Blake JM, Evans CV, Webber EM, Coppola EL, Perdue LA, Weyrich MS. Screening for hypertension in adults: updated evidence report and systematic review for the us preventive services task force. JAMA. 2021;325:1657–69.PubMedCrossRef
126.
go back to reference Williams B, Mancia G, Spiering W, Agabiti Rosei E, Azizi M, Burnier M, et al. Members: ATF: 2018 ESC/ESH guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European society of cardiology and the European society of hypertension. J Hypertens. 2018;36:1953–2041.PubMedCrossRef Williams B, Mancia G, Spiering W, Agabiti Rosei E, Azizi M, Burnier M, et al. Members: ATF: 2018 ESC/ESH guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European society of cardiology and the European society of hypertension. J Hypertens. 2018;36:1953–2041.PubMedCrossRef
127.
go back to reference Unger T, Borghi C, Charchar F, Khan NA, Poulter NR, Prabhakaran D, et al. 2020 international society of hypertension global hypertension practice guidelines. Hypertension. 2020;75:1334–57.PubMedCrossRef Unger T, Borghi C, Charchar F, Khan NA, Poulter NR, Prabhakaran D, et al. 2020 international society of hypertension global hypertension practice guidelines. Hypertension. 2020;75:1334–57.PubMedCrossRef
128.
go back to reference Nerenberg KA, Zarnke KB, Leung AA, Dasgupta K, Butalia S, McBrien K, et al. Hypertension Canada’s 2018 guidelines for diagnosis, risk assessment, prevention, and treatment of hypertension in adults and children. Can J Cardiol. 2018;34:506–25.PubMedCrossRef Nerenberg KA, Zarnke KB, Leung AA, Dasgupta K, Butalia S, McBrien K, et al. Hypertension Canada’s 2018 guidelines for diagnosis, risk assessment, prevention, and treatment of hypertension in adults and children. Can J Cardiol. 2018;34:506–25.PubMedCrossRef
129.
go back to reference Whelton PK, Appel L, Charleston J, Dalcin AT, Ewart C, Fried L, Kaidy D, Klag MJ, Kumanyika S, Steffen L, Walker WG. The effects of nonpharmacologic interventions on blood pressure of persons with high normal levels: results of the Trials of Hypertension Prevention, phase I. Jama. 1992;267(9):1213–20.CrossRef Whelton PK, Appel L, Charleston J, Dalcin AT, Ewart C, Fried L, Kaidy D, Klag MJ, Kumanyika S, Steffen L, Walker WG. The effects of nonpharmacologic interventions on blood pressure of persons with high normal levels: results of the Trials of Hypertension Prevention, phase I. Jama. 1992;267(9):1213–20.CrossRef
130.
go back to reference The Trials Of Hypertension Prevention Collaborative Research Group. Effects of weight loss and sodium reduction intervention on blood pressure and hypertension incidence in overweight people with high-normal blood pressure. The trials of hypertension prevention, phase ii. Arch Intern Med. 1997;157:657–67.CrossRef The Trials Of Hypertension Prevention Collaborative Research Group. Effects of weight loss and sodium reduction intervention on blood pressure and hypertension incidence in overweight people with high-normal blood pressure. The trials of hypertension prevention, phase ii. Arch Intern Med. 1997;157:657–67.CrossRef
131.
go back to reference Whelton PK, Appel LJ, Espeland MA, Applegate WB, Ettinger WH, Kostis JB, et al. Sodium reduction and weight loss in the treatment of hypertension in older persons: a randomized controlled trial of nonpharmacologic interventions in the elderly (tone). JAMA. 1998;279:839–46.PubMedCrossRef Whelton PK, Appel LJ, Espeland MA, Applegate WB, Ettinger WH, Kostis JB, et al. Sodium reduction and weight loss in the treatment of hypertension in older persons: a randomized controlled trial of nonpharmacologic interventions in the elderly (tone). JAMA. 1998;279:839–46.PubMedCrossRef
132.
133.
go back to reference He J, Whelton PK, Appel LJ, Charleston J, Klag MJ. Long-term effects of weight loss and dietary sodium reduction on incidence of hypertension. Hypertension. 2000;35:544–9.PubMedCrossRef He J, Whelton PK, Appel LJ, Charleston J, Klag MJ. Long-term effects of weight loss and dietary sodium reduction on incidence of hypertension. Hypertension. 2000;35:544–9.PubMedCrossRef
134.
go back to reference Stamler R, Stamler J, Gosch FC, Civinelli J, Fishman J, McKeever P, et al. Primary prevention of hypertension by nutritional-hygienic means. Final report of a randomized, controlled trial. JAMA. 1989;262:1801–7.PubMedCrossRef Stamler R, Stamler J, Gosch FC, Civinelli J, Fishman J, McKeever P, et al. Primary prevention of hypertension by nutritional-hygienic means. Final report of a randomized, controlled trial. JAMA. 1989;262:1801–7.PubMedCrossRef
135.
go back to reference Takahashi Y, Sasaki S, Okubo S, Hayashi M, Tsugane S. Blood pressure change in a free-living population-based dietary modification study in Japan. J Hypertens. 2006;24:451–8.PubMedCrossRef Takahashi Y, Sasaki S, Okubo S, Hayashi M, Tsugane S. Blood pressure change in a free-living population-based dietary modification study in Japan. J Hypertens. 2006;24:451–8.PubMedCrossRef
136.
go back to reference Whelton PK, He J, Appel LJ, Cutler JA, Havas S, Kotchen TA, et al. Committee NHBPEPC: Primary prevention of hypertension: clinical and public health advisory from the national high blood pressure education program. JAMA. 2002;288:1882–8.PubMedCrossRef Whelton PK, He J, Appel LJ, Cutler JA, Havas S, Kotchen TA, et al. Committee NHBPEPC: Primary prevention of hypertension: clinical and public health advisory from the national high blood pressure education program. JAMA. 2002;288:1882–8.PubMedCrossRef
137.
138.
go back to reference Meade TW, Haines AP, North WR, Chakrabarti R, Howarth DJ, Stirling Y. Haemostatic, lipid, and blood-pressure profiles of women on oral contraceptives containing 50 microgram or 30 microgram oestrogen. Lancet. 1977;2:948–51.PubMedCrossRef Meade TW, Haines AP, North WR, Chakrabarti R, Howarth DJ, Stirling Y. Haemostatic, lipid, and blood-pressure profiles of women on oral contraceptives containing 50 microgram or 30 microgram oestrogen. Lancet. 1977;2:948–51.PubMedCrossRef
139.
140.
go back to reference Liu H, Yao J, Wang W, Zhang D. Association between duration of oral contraceptive use and risk of hypertension: a meta-analysis. J Clin Hypertens (Greenwich). 2017;19:1032–41.PubMedCrossRef Liu H, Yao J, Wang W, Zhang D. Association between duration of oral contraceptive use and risk of hypertension: a meta-analysis. J Clin Hypertens (Greenwich). 2017;19:1032–41.PubMedCrossRef
141.
go back to reference American College of Obstetricians and Gynecologists. Hypertension in pregnancy. Report of the American College of Obstetricians and Gynecologists’ task force on hypertension in pregnancy. Obstet Gynecol. 2013;122(5):1122–31. American College of Obstetricians and Gynecologists. Hypertension in pregnancy. Report of the American College of Obstetricians and Gynecologists’ task force on hypertension in pregnancy. Obstet Gynecol. 2013;122(5):1122–31.
143.
go back to reference Wright JT, Williamson JD, Whelton PK, Snyder JK, Sink KM, Rocco MV, et al. A randomized trial of intensive versus standard blood-pressure control. N Engl J Med. 2015;373:2103–16.PubMedCrossRef Wright JT, Williamson JD, Whelton PK, Snyder JK, Sink KM, Rocco MV, et al. A randomized trial of intensive versus standard blood-pressure control. N Engl J Med. 2015;373:2103–16.PubMedCrossRef
144.
go back to reference Scott PE, Unger EF, Jenkins MR, Southworth MR, McDowell TY, Geller RJ, et al. Participation of women in clinical trials supporting FDA approval of cardiovascular drugs. J Am Coll Cardiol. 2018;71:1960–9.PubMedCrossRef Scott PE, Unger EF, Jenkins MR, Southworth MR, McDowell TY, Geller RJ, et al. Participation of women in clinical trials supporting FDA approval of cardiovascular drugs. J Am Coll Cardiol. 2018;71:1960–9.PubMedCrossRef
145.
go back to reference Jin X, Chandramouli C, Allocco B, Gong E, Lam CSP, Yan LL. Women’s participation in cardiovascular clinical trials from 2010 to 2017. Circulation. 2020;141:540–8.PubMedCrossRef Jin X, Chandramouli C, Allocco B, Gong E, Lam CSP, Yan LL. Women’s participation in cardiovascular clinical trials from 2010 to 2017. Circulation. 2020;141:540–8.PubMedCrossRef
Metadata
Title
Hypertension Across a Woman’s Life Cycle
Authors
Lama Ghazi
Rahul V. Annabathula
Natalie A. Bello
Li Zhou
Richard Brandon Stacey
Bharathi Upadhya
Publication date
09-11-2022
Publisher
Springer US
Published in
Current Hypertension Reports / Issue 12/2022
Print ISSN: 1522-6417
Electronic ISSN: 1534-3111
DOI
https://doi.org/10.1007/s11906-022-01230-4

Other articles of this Issue 12/2022

Current Hypertension Reports 12/2022 Go to the issue

Implementation to Increase Blood Pressure Control: What Works? (J Brettler and K Reynolds, Section Editors)

Strategies to Improve Medication Adherence and Blood Pressure Among Racial/Ethnic Minority Populations: A Scoping Review of the Literature from 2017 to 2021

Hypertension and the Brain (I Nasrallah, Section Editor)

Effects of Hypertension on Alzheimer’s Disease and Related Disorders

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.